Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 10.30
-0.20 (-1.90%)
Aug 1, 2025, 2:59 PM CST
Chimerix Market Cap
TPEX:4186 has a market cap or net worth of 927.00 million as of August 1, 2025. Its market cap has decreased by -47.98% in one year.
Market Cap
927.00M
Enterprise Value
1.05B
Revenue
354.17M
Ranking
n/a
PE Ratio
41.20
Stock Price
$10.30
Market Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 927.00M, a decrease of -77.38%. That is a compound annual growth rate of -11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 927.00M | -34.60% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | 2.28B | 53.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 187.67B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 85.54B |
| Lotus Pharmaceutical | 56.54B |
| Oneness Biotech | 29.80B |
| Polaris Group | 27.62B |
| Center Laboratories | 26.60B |
| Pegavision | 23.91B |